BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.

BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.

Our team has grown significantly and we now proudly employ over 400 highly skilled individuals. Despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.

The Prenatal Account Manager, Miami (Hialeah to Florida Keys) is an outstanding prenatal sales executive with experience in diagnostic/genetic testing product sales, who will bring the first and only single-gene NIPT supported carrier, fetal antigen, and aneuploidy screen to OBGYN clinics & MFMs throughout the Miami (Hialeah to Florida Keys) territory. You will deliver clinical insights to both external accounts throughout the Miami (Hialeah to Florida Keys) territory and internal teams. You will have significant influence over how the test is communicated to physicians and patients, and how it should evolve to better serve market needs. This is a remote position and reports to the Regional Manager - Prenatal, Florida.

Responsibilities:

• Increasing revenue and driving market development through direct sales to individual OBGYNs, MFMs, and Genetic Counselors.
• Creating and implementing a strategic business plan to grow revenue quickly in your geography.
• Sales efforts include effective prospecting and cultivating new business, and maintaining key relationships.

Requirements:

• Minimum three (3) years of Women's Health sales experience at a genetics or diagnostics company covering Miami (Hialeah to Florida Keys); if lacking direct genetics or diagnostics industry experience, must have medical device or pharma experience directly calling upon OBGYNs, MFMs, etc. with existing book of convertible client relationships
• Bilingual/Spanish is a must
• Demonstrated successful sales track record (eg. multiple award winning - President Club or equivalent required), solid negotiation skills, understanding of buyer/decision maker types, exhibit effective selling, listening, presentation skills, and ability to assess and respond to customer needs
• Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers.
• Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
• Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically
• Must act with a sense of urgency, with a focus on closing business
• Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving
• Strong desire to work in a startup environment and must work independently with an internal drive to be successful

Nice-to-Haves:

• Experience in a start-up environment
• Clinical laboratory experience

Benefits And Perks:

• Working with a team of ‘rockstars’ who bring out the best in everyone
• Open, transparent culture that includes weekly Town Hall meetings
• The ability to indirectly or directly change the lives of hundreds of thousand patients
• Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
• Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
• Retirement savings program including a 4% Company match
• Free daily on-site lunches provided from top eateries
• Latest and greatest hardware (laptop, lab equipment, facilities)
• A variety of perks on campus (state of the art gym, restaurant)
• Free on-site EV charging (compatible with all EVs, including Tesla)

At BillionToOne, we are proud to offer a combination of a (1) base pay (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).

This position offers a starting package of a base of $115,000 & total compensation of $165,000, if at plan, with opportunities for promotion. Commissions potential is uncapped and can be significant.